Dabomb Protein Biotech (ROCO:6578) YoY EBITDA Growth : 251.91% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Dabomb Protein Biotech's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 251.91%.

Dabomb Protein Biotech's EBITDA per Share for the three months ended in Mar. 2024 was NT$0.20.

Dabomb Protein Biotech YoY EBITDA Growth Historical Data

The historical data trend for Dabomb Protein Biotech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech YoY EBITDA Growth Chart

Dabomb Protein Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

-2.64

-20.46

-204.66

68.18

-21.50

Dabomb Protein Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-31.00	87.03	-756.60	121.55	251.91

Dabomb Protein Biotech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Dabomb Protein Biotech's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.486	-	-0.4)	/	\| -0.4 \|
=	-21.50 %

Dabomb Protein Biotech's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(0.199	-	-0.131)	/	\| -0.131 \|
=	251.91 %

Dabomb Protein Biotech YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Dabomb Protein Biotech's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Dabomb Protein Biotech (ROCO:6578) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 52, Gongye 3rd Road, Annan District, Tainan, TWN, 709

Website

https://www.dabombprotein.com

Dabomb Protein Biotech Corp is a company specializing in antibiotic alternatives, and use postbiotics to boost immune strength and excel in innovative fermentation for improved plant protein utility. Their portfolio of products which include DBT-100 LS and DBT-100 HT , Liqui-TIDE bandage and LACTOTIDES HEALTH A+.

Dabomb Protein Biotech (ROCO:6578) Headlines

No Headlines